There are a few key trends to look for if we want to identify the next multi-bagger. Firstly, we'd want to identify a growing return on capital employed (ROCE) and then alongside that, an ...
With its stock down 11% over the past three months, it is easy to disregard Computer Modelling Group (TSE:CMG). However, the company's fundamentals look pretty decent, and long-term financials are ...
Computer Modelling Group basically offers physics-based reservoir and seismic simulation software. They operate under two segments. Their first one is the high-margin reservoir & production simulation ...
Computer Modelling Group acquires subsurface software and services provider Bluware for $22MM and reports strong Q2 results. Weakening energy markets and industry consolidation in the US are likely to ...
A research team has created a computer modelling program to help scientists predict the effect of climate damage and eventual restoration plans on coral reefs around the globe. This is a critical ...
Computer Modelling (TSE:CMG) has released an update. Computer Modelling Group Ltd. reports a robust year-end, with a 59% increase in fourth-quarter revenue to $32.3 million and a 38% rise in net ...
Materials surround us—from raw materials such as metal ores in the earth, protein biomaterials in our bodies to functional materials that power electronic devices. Science and engineering demands the ...
In what could totally change the very fabric of computer modelling calculations, a team from MIT in the US has created a new “bull’s eye” algorithm that can make modelling 200-times faster than before ...
As computing power continues to grow, theoretical physicists have been able to do larger and more complicated simulations. Running these models consumes a growing amount of energy, and for the time ...
How can computer modelling help food manufacturers optimise their production processes? René Floris, NIZO Food Research Division Manager and member of the FoodNavigator expert advisory panel explores ...
When Moderna joined the hunt for a coronavirus vaccine in early 2020, the company had only limited clinical experience with its technology. Scientists had tested the company’s messenger RNA ...